Developer docs
API playgroundTry for free, no card

Search company profiles

Overture Life

Full company profile

uuid00007dg

Namestring
Overture Life
Legal namestring
Overture Life SLU
Websiteurl
overture.life
Company typeenum
Private
Founded yearint
2017
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersPalo Alto, United States
HQ citystring
Palo Alto
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
automated IVF technology, embryology automation, vitrification platforms, embryo assessment testing, assisted reproductive technology
Industry2 codes
PRIMARYHLAAALAJ
Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening)
SECONDARYHLAFAJAD
Fertility, Reproductive Endocrinology & IVF Centers
Healthcare & Life Sciences/Healthcare Providers & Systems/Women’s & Children’s Health Providers
NAICS code2 codes
  • Surgical Appliance and Supplies Manufacturing339113
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
IVF Automation / Reproductive Medical Devices
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1DaVitri Platform Sales and Licensing
TypeOne Time License
Description

The company generates revenue through sale and licensing of its DaVitri automated vitrification platform to fertility clinics. The platform is deployed as a service-supported system, with clinics paying for access to the technology.

businesswire.com
2MZ Metabolomics Testing Services
TypeProfessional Services
Description

Revenue from non-invasive embryo assessment testing services performed at CLIA-licensed laboratories using mass spectrometry and machine learning to predict embryo viability.

businesswireindia.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Operations, Personnel, Supply Chain, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1DaVitri
Description

Automated vitrification platform for egg freezing and embryo warming using microfluidic technology

overture.life
+2 more records
Core offering1 text field

Overture Life develops and commercializes automated hardware and consumable platforms for in vitro fertilization (IVF) laboratories. Its core products are DaVitri, an automated microfluidic vitrification platform for egg freezing and embryo warming; m/z, a non-invasive metabolomics embryo assessment test using mass spectrometry and machine learning; and ICSI, a robotic intracytoplasmic sperm injection system. These products are sold and licensed to fertility clinics to reduce operator-dependent variability, increase throughput, and lower infrastructure costs.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 12% improvement in egg survival rates with DaVitri platform
+3 more records
Product overview1 text field

Overture Life is an embryology automation company offering three core products: DaVitri (automated vitrification platform for egg freezing and embryo warming using microfluidic technology), m/z (non-invasive embryo assessment using metabolomics and machine learning), and ICSI (robotic sperm injection system). The company operates in Spain and the US with global expansion across Europe, UAE, India, and Brazil. Products are designed to automate complex IVF procedures, reduce costs, improve clinical outcomes, and enable fertility clinics to scale operations.

Product and service3 records
1DaVitri
CategoryAutomated vitrification hardware platform
Description

Automated vitrification platform that automates the egg-freezing and embryo-warming process through a microfluidic system. Demonstrates 12% improvement in egg survival rates and threefold throughput gains compared to manual methods. Regulatory cleared across US, Europe, South America, UAE, and India. Sold and licensed to fertility clinics seeking to standardize vitrification outcomes.

2m/z
CategoryEmbryo assessment testing service
Description

Non-invasive embryo assessment platform using metabolomics analysis of spent embryo culture media. Combines mass spectrometry with machine learning to predict embryo implantation with 85% accuracy, offering an alternative to traditional PGT-A testing methods. Performed as a service at CLIA-licensed laboratories for fertility clinics and IVF centers.

3ICSI
CategoryRobotic ICSI hardware platform
Description

Robotic intracytoplasmic sperm injection platform enabling automated sperm injection procedures as part of the IVF process. Part of Overture Life's portfolio of automated embryology solutions targeting fertility clinics.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Emitac Healthcare Solutions
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-06-17
Description

Overture Life and Emitac Healthcare Solutions partnership aims to address operator-dependent variability in embryology procedures and enable UAE clinics to scale advanced fertility services while reducing infrastructure costs.

businesswire.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers8 records
TypeDirect peer
Description

TMRW Life Sciences provides automated cryostorage for eggs and embryos in IVF, making it the closest direct competitor to Overture's DaVitri automated vitrification platform. Both companies are pursuing software-and-robotic automation of IVF lab workflows with similar regulatory and clinic-adoption pathways.

TypeDirect peer
Description

Hamilton Thorne manufactures precision instruments and automation for the IVF and animal breeding markets, including laser systems and embryo/vitrification devices. It directly competes with Overture in the embryology lab equipment category serving fertility clinics globally.

TypeDirect peer
Description

Genea Biomedx (the device arm of Genea) develops IVF lab automation and consumables including time-lapse incubators and culture systems. It targets the same fertility clinic automation category as Overture's DaVitri and ICSI platforms.

TypeBroad incumbent
Description

Vitrolife is a publicly traded global leader in IVF media, consumables, and time-lapse incubation systems. It overlaps with Overture across the embryology lab workflow but offers a much broader portfolio rather than specializing in automation.

TypeBroad incumbent
Description

CooperSurgical provides a broad portfolio of fertility, genomics, and women's health products including IVF lab equipment, microtools, and genetic testing. It is an incumbent that competes across multiple IVF categories Overture serves.

TypeBroad incumbent
Description

FUJIFILM Irvine Scientific supplies cell culture media, IVF products, and biorepository solutions to the assisted reproductive technology market. It is a broad incumbent in embryology lab consumables and adjacent equipment categories.

TypeOthers
Description

Progyny is a fertility benefits management company that channels employer-sponsored patients to IVF clinics. While not a technology competitor, it shapes demand dynamics for IVF automation tools like DaVitri and is thematically adjacent to the fertility ecosystem Overture serves.

TypeOthers
Description

Natera provides reproductive genetic testing including PGT-A and NIPT services to IVF clinics and patients. Its preimplantation genetic testing product competes with Overture's MZ metabolomics embryo assessment platform as an alternative embryo selection modality.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors11 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Overture Life

IVF Automation / Reproductive Medical Devicesoverture.life

Overture Life firmographics

Firmographics
Name
Overture Life
Legal name
Overture Life SLU
Website
https://overture.life
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Overture Life industry classification

Industry
Product category
IVF Automation / Reproductive Medical Devices
NAICS
Surgical Appliance and Supplies Manufacturing (339113), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Surgical & Medical Instruments & Apparatus (3841), In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAAALAJ
Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening)
SECONDARYHLAFAJAD
Fertility, Reproductive Endocrinology & IVF Centers
Healthcare & Life Sciences/Healthcare Providers & Systems/Women’s & Children’s Health Providers

Keywords

  • Automated IVF technology
  • Embryology automation
  • Vitrification platforms
  • Embryo assessment testing
  • Assisted reproductive technology

Where Overture Life is headquartered

Location

Headquarters

HQ city
Palo Alto
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Overture Life business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Operations, Personnel, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

  1. DaVitri Platform Sales and Licensing: The company generates revenue through sale and licensing of its DaVitri automated vitrification platform to fertility clinics. The platform is deployed as a service-supported system, with clinics paying for access to the technology.
  2. MZ Metabolomics Testing Services: Revenue from non-invasive embryo assessment testing services performed at CLIA-licensed laboratories using mass spectrometry and machine learning to predict embryo viability.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Overture Life product offering

Product offering

Core offering

Overture Life develops and commercializes automated hardware and consumable platforms for in vitro fertilization (IVF) laboratories. Its core products are DaVitri, an automated microfluidic vitrification platform for egg freezing and embryo warming; m/z, a non-invasive metabolomics embryo assessment test using mass spectrometry and machine learning; and ICSI, a robotic intracytoplasmic sperm injection system. These products are sold and licensed to fertility clinics to reduce operator-dependent variability, increase throughput, and lower infrastructure costs.

Product overview

Overture Life is an embryology automation company offering three core products: DaVitri (automated vitrification platform for egg freezing and embryo warming using microfluidic technology), m/z (non-invasive embryo assessment using metabolomics and machine learning), and ICSI (robotic sperm injection system). The company operates in Spain and the US with global expansion across Europe, UAE, India, and Brazil. Products are designed to automate complex IVF procedures, reduce costs, improve clinical outcomes, and enable fertility clinics to scale operations.

Differentiator

Problem solved

Functional benefit

Brands

  • DaVitri: Automated vitrification platform for egg freezing and embryo warming using microfluidic technology
  • MZ
  • ICSI

Products and services

  • DaVitri Automated vitrification platform that automates the egg-freezing and embryo-warming process through a microfluidic system. Demonstrates 12% improvement in egg survival rates and threefold throughput gains compared to manual methods. Regulatory cleared across US, Europe, South America, UAE, and India. Sold and licensed to fertility clinics seeking to standardize vitrification outcomes.
  • m/z Non-invasive embryo assessment platform using metabolomics analysis of spent embryo culture media. Combines mass spectrometry with machine learning to predict embryo implantation with 85% accuracy, offering an alternative to traditional PGT-A testing methods. Performed as a service at CLIA-licensed laboratories for fertility clinics and IVF centers.
  • ICSI Robotic intracytoplasmic sperm injection platform enabling automated sperm injection procedures as part of the IVF process. Part of Overture Life's portfolio of automated embryology solutions targeting fertility clinics.

Quantifiable outcome

  • 12% improvement in egg survival rates with DaVitri platform
  • +3 more outcomes

Companies that use Overture Life

Customer profile

Segments1 record

Ideal customer profiles2 records

Overture Life technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Overture Life partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Emitac Healthcare SolutionscoreChannel Partner/ Reseller/ Distributor · 17 June 2026Overture Life and Emitac Healthcare Solutions partnership aims to address operator-dependent variability in embryology procedures and enable UAE clinics to scale advanced fertility services while reducing infrastructure costs.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Overture Life competitors and assessment

Company assessment

Direct peers

  • TMRW Life Sciences: TMRW Life Sciences provides automated cryostorage for eggs and embryos in IVF, making it the closest direct competitor to Overture's DaVitri automated vitrification platform. Both companies are pursuing software-and-robotic automation of IVF lab workflows with similar regulatory and clinic-adoption pathways.
  • Hamilton Thorne: Hamilton Thorne manufactures precision instruments and automation for the IVF and animal breeding markets, including laser systems and embryo/vitrification devices. It directly competes with Overture in the embryology lab equipment category serving fertility clinics globally.
  • Genea Biomedx: Genea Biomedx (the device arm of Genea) develops IVF lab automation and consumables including time-lapse incubators and culture systems. It targets the same fertility clinic automation category as Overture's DaVitri and ICSI platforms.

Broad incumbents

  • Vitrolife: Vitrolife is a publicly traded global leader in IVF media, consumables, and time-lapse incubation systems. It overlaps with Overture across the embryology lab workflow but offers a much broader portfolio rather than specializing in automation.
  • CooperSurgical: CooperSurgical provides a broad portfolio of fertility, genomics, and women's health products including IVF lab equipment, microtools, and genetic testing. It is an incumbent that competes across multiple IVF categories Overture serves.
  • FUJIFILM Irvine Scientific: FUJIFILM Irvine Scientific supplies cell culture media, IVF products, and biorepository solutions to the assisted reproductive technology market. It is a broad incumbent in embryology lab consumables and adjacent equipment categories.

Others

  • Progyny: Progyny is a fertility benefits management company that channels employer-sponsored patients to IVF clinics. While not a technology competitor, it shapes demand dynamics for IVF automation tools like DaVitri and is thematically adjacent to the fertility ecosystem Overture serves.
  • Natera: Natera provides reproductive genetic testing including PGT-A and NIPT services to IVF clinics and patients. Its preimplantation genetic testing product competes with Overture's MZ metabolomics embryo assessment platform as an alternative embryo selection modality.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Overture Life social profiles

Digital presence

Overture Life compliance and trust

Trust signal

Compliance4 records

Overture Life financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Overture Life leadership team

Management profile

Number of profiles

Profiles8 records

Overture Life funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors11 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Overture Life M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Overture Life

What does Overture Life do?

Overture Life develops and commercializes automated hardware and consumable platforms for in vitro fertilization (IVF) laboratories. Its core products are DaVitri, an automated microfluidic vitrification platform for egg freezing and embryo warming; m/z, a non-invasive metabolomics embryo assessment test using mass spectrometry and machine learning; and ICSI, a robotic intracytoplasmic sperm injection system. These products are sold and licensed to fertility clinics to reduce operator-dependent variability, increase throughput, and lower infrastructure costs.

Is Overture Life a public or private company?

Overture Life is a private company. It is classified as venture growth investor backed and is currently operating.

When was Overture Life founded?

Overture Life was founded in 2017. It employs 11 to 50 people.

Where is Overture Life based?

Overture Life is headquartered in Palo Alto, United States, in the North America region.

How does Overture Life make money?

Two revenue lines are on record. DaVitri Platform Sales and Licensing is the primary driver. The others are MZ Metabolomics Testing Services.

Who are Overture Life's main competitors?

Direct peers on record are TMRW Life Sciences, Hamilton Thorne and Genea Biomedx. Broad incumbents are Vitrolife, CooperSurgical and FUJIFILM Irvine Scientific. Others are Progyny and Natera.

Does Overture Life have an API?

No public API is recorded for Overture Life.

What industry is Overture Life in?

Overture Life's product category is IVF Automation / Reproductive Medical Devices. Its primary akta.pro industry code is HLAAALAJ, Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening), with a secondary code of HLAFAJAD, Fertility, Reproductive Endocrinology & IVF Centers. Its NAICS code is 339113 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The CEO Magazine IndiaOverture Life’s DaVitri automated egg freezing tech enables higher embryo yield in IndiaHana Health, DSS Imagetech's IVF arm, announced exclusive India availability of Overture Life's DaVitri automated egg-freezing system. The device integrates automation and microfluidic technology to standardize oocyte vitrification, reducing manual workload. Overture Life aims to make IVF more accessible and affordable worldwide.The TribuneOverture Life’s DaVitri automated egg freezing tech enables higher embryo yield in India - The TribuneHana Health, the IVF arm of DSS Imagetech, announced exclusive India availability of DaVitri, an automated egg-freezing system from Overture Life. The system automates oocyte vitrification, reducing manual workload and improving precision. Overture Life aims to make IVF more accessible and affordable worldwide.Business Wire BlogOverture Life Launches Global ICSI.A Center of Excellence Program, Bringing the World's First Automated ICSI into Clinical Use Across Five Leading Global Fertility CentersOverture Life announced the launch of its ICSI.A Center of Excellence Program, deploying the world's first automated intracytoplasmic sperm injection workstation at five leading fertility centers across Peru, Turkey, Bolivia, South Korea, and Argentina. The platform introduces robotics and computer vision to standardize the most technically demanding step in IVF, which previously depended entirely on individual embryologist skill and dexterity. The company plans to expand the program to additional leading fertility networks worldwide and will generate real-world operational data to inform best practices for automated embryology.Business Wire BlogOverture Life Expands Global Footprint with UAE Launch, Partnering with Emitac Healthcare Solutions to Bring Automated IVF to the GulfOverture Life announced a strategic partnership with Emitac Healthcare Solutions to launch its DaVitri automated IVF laboratory platform across UAE fertility clinics, marking the company's first entry into the Middle East market. The DaVitri platform, which automates vitrification through a microfluidic system and has been cleared by the UAE Ministry of Health and Prevention, is now the most broadly authorized automated IVF platform globally with regulatory clearances across the United States, Europe, South America, and the UAE. Overture Life, which previously launched in Brazil and India, plans continued expansion across the Gulf and broader Middle East as part of its ongoing global commercialization strategy.Business Wire BlogOverture Life and Tekservis Partner, Deploying Automated Egg and Embryo Freezing Across Turkey's Fertility ClinicsOverture Life and Tekservis announced a nationwide partnership to deploy DaVitri automated egg and embryo freezing across Turkey's fertility clinics. The platform uses microfluidics to standardize vitrification, reducing operator-dependent variation. The rollout focuses on vitrification initially, with further expansion dependent on regulatory pathways and clinic integration.Business Wire IndiaDSS Imagetech की Hana Health ने Overture Life के साथ पार्टनरशिप कर विश्व की पहली स्वचालित एग-फ्रीजिंग टेक्नोलॉजी भारत में लाने की घोषणा कीHana Health, a division of DSS Imagetech, has entered into an exclusive partnership with Overture Life to launch DaVitri, the world's first automated egg-freezing platform, in India. Overture Life is the company that achieved the world's first live births through robotic fertilization and robotic egg-freezing, and its DaVitri platform has received regulatory clearance from US, UK, and European authorities. The technology is designed to standardize vitrification in fertility clinics, reduce procedural variability, increase throughput without adding staff, and lower infrastructure costs to enable smaller clinics and satellite locations to offer advanced IVF services.Business Wire BlogHana Health by DSS Imagetech Partners with Overture Life to Bring World-First Automated Egg-Freezing Technology to IndiaHana Health by DSS Imagetech has partnered with Overture Life to bring the DaVitri automated egg-freezing technology to India for the first time, enabling fertility clinics to standardize vitrification, a technically demanding step in IVF. DaVitri is the first automation platform to receive regulatory clearance from major authorities in the US, UK, and Europe, and has demonstrated measurable improvements in post-thaw embryo development compared with manual methods in clinical evaluations. The collaboration aims to expand procedural capacity and address India's rapidly growing fertility demand while reducing infrastructure costs for smaller clinics.Business Wire IndiaHana Health by DSS Imagetech Partners with Overture Life to Bring World-First Automated Egg-Freezing Technology to IndiaHana Health by DSS Imagetech has exclusively partnered with Overture Life to bring the DaVitri automated egg-freezing technology to India, marking the first availability of this regulatory-cleared system in the country. The technology aims to standardize vitrification — one of IVF's most technically demanding steps — reducing variability that contributes to inconsistent results and repeated treatment cycles, while enabling clinics to expand procedural capacity at a fraction of current infrastructure costs. The collaboration positions DaVitri as a forthcoming service-supported system for Indian fertility clinics seeking to modernize IVF workflows amid the country's rapidly growing fertility demand.